AbCellera Biologics Inc vs Victoria's Secret & Co — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while Victoria's Secret & Co trades at $94.76 (market cap $7.48B). The key difference: Victoria's Secret & Co is far larger — about 2.5× AbCellera Biologics Inc's market cap. Which is the better fit depends on your goals.
| ABCL | VSXY | |
|---|---|---|
Market Cap | $2.99B | $7.48B |
Sector | Health | Consumer Cyclical |
52-Week High | $9.76 | $99.97 |
52-Week Low | $2.78 | $21.34 |
Enterprise Value | $2.58B | $10.13B |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →